about
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaPathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutationsComprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomasHistopathology of BRCA1- and BRCA2-associated breast cancer.Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.Municipal distribution and trends in bladder cancer incidence in health area of León, Spain (1996-2010).Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.[Hospital incidence, trends and municipal distribution of prostate cancer in health area of León, Spain (1996-2010)].Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.[Chronic diarrhea associated with a lymphoproliferative process].The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.[Municipal distribution and trend of the incidence of breast cancer in the health area of León, Spain (1996-2010)].MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaA predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylationEstrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast CancerDifferential expression of NF-κB pathway genes among peripheral T-cell lymphomasImmunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated TumorsA novel candidate region linked to development of both pheochromocytoma and head/neck paragangliomaGenomic analysis of the 8p11-12 amplicon in familial breast cancerClassification of missense variants of unknown significance inBRCA1based on clinical and tumor informationGain-of-function mutations in DNMT3A in patients with paragangliomaIdentification of a Proliferation Signature Related to Survival in Nodal Peripheral T-Cell Lymphomas[Primary hepatic leiomyosarcoma in a patient with gastric non-Hodgkin lymphoma]Group A streptococcal septic vasculitis in a child with dengue hemorrhagic feverERBB2 and MYC alterations in BRCA1- and BRCA2-associated cancersThe accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors[Sarcomatoid carcinoma in a patient with Sjögren's syndrome]Perineurial cells in granular cell tumors and neoplasms with perineural invasion: an immunohistochemical studyIntraneural hybrid granular cell tumor-perineurioma
P50
Q28241168-B3F711EF-641E-495C-9CF6-C109F300276FQ28265304-2FF1E2AB-32EE-4E6C-9A7C-0AFA760B5903Q33627191-95A84A6B-AC67-43A8-86C2-641ED6A8A9CDQ35984566-DFDD80F6-FE92-4BA6-A5C4-AEF49E442FD8Q36418567-8571A0A2-199D-418C-809A-6363019A729AQ39076251-178F6FB2-F0B0-4014-9C49-F538B7B35F8AQ40257162-4ADE5119-FEAB-4AD4-8B8A-69358481437EQ40303976-AF2E1C65-F837-41E9-B025-24BC21D0D628Q40965217-228EEDA8-D0CC-4791-AB96-3B5966814E8CQ42461178-883D3D5D-5227-4BAF-8D4A-3A1F355EA848Q42475630-FBCD3C01-98D3-4DAC-9FA3-D628BC806FB0Q42491999-D272037F-C0AA-4672-943D-A578F0791E58Q42519156-F32C9E77-F983-4A39-A80A-280771CBE16BQ44594038-456C63D7-C2A3-45AB-B5B3-3E6B4BD0BFB9Q45833321-EDFF35B9-6902-4512-8258-AD11E287426FQ46732136-0D872253-6009-4397-8050-5F19C87BEA80Q50202366-312737A3-5C78-4F3F-B04C-84486A8A9C6AQ51248830-72B9A38F-C0A5-425F-B441-E6C808CDF24EQ56964302-99CD0A58-1B5B-41F9-ADA0-FCCE048CB1A4Q57239985-89AEE5C8-E52A-49F9-BCF6-E51684C53811Q57272206-D6B601C7-B975-4228-BD06-203974DB0609Q57279479-27A6F1DF-DBED-4FD5-9A14-DFD8DDAE252CQ57306220-18D341DF-FAC3-4708-9017-AF1120D826EEQ57963898-457559A0-1CD6-4B9B-8A03-35563C5E626AQ58613291-A0B22AE0-FDF7-47C0-8A9A-CDAECDD67D63Q59538992-20848F61-3445-4896-96C0-706A2BBAB1DBQ60895552-11614472-8622-4E4A-BE08-3E4E7C06A47AQ61822347-A32CECAC-CBE2-41E2-ADB2-1C7A2002166FQ74517759-5E39A5E7-CDFA-43C9-AA30-8922C33FDD56Q79446803-5105AE41-336A-4CC6-B9F9-BF1AB080B36FQ81006822-313E0D7D-DDEF-49E7-B31F-3152C50AACA4Q81639115-EC947254-859A-448F-A26A-AA15454D270FQ83384121-DBE4E258-7F06-4BBF-9407-D6C1A9C9499AQ84299738-3B87763B-5AAE-484B-AF6A-356F77B8A9B5Q85820545-8C81984F-72A4-4A3A-8795-1034E0F965C2
P50
description
forsker
@nb
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
E. Honrado
@ast
E. Honrado
@nl
Emiliano Honrado
@en
Emiliano Honrado
@es
Emiliano Honrado
@nb
type
label
E. Honrado
@ast
E. Honrado
@nl
Emiliano Honrado
@en
Emiliano Honrado
@es
Emiliano Honrado
@nb
altLabel
E. Honrado
@en
prefLabel
E. Honrado
@ast
E. Honrado
@nl
Emiliano Honrado
@en
Emiliano Honrado
@es
Emiliano Honrado
@nb
P106
P31
P496
0000-0001-5668-4083